Major partnership expansion with Boehringer Ingelheim: Amendment of the collaboration and licensing agreement on first-in-class SIRPα compounds already developed in immuno-oncology, now expected ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

That said, I also cited a quote from a co-moderator of that study ... in February this year, Boehringer Ingelheim and Zealand Pharma's GLP-1 agonist drug reported data from a Phase 2 study in ...

Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches BARCELONA, Spain, Nov. 14, 2024 /PRNewswire/ -- Veeva Systems ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales into researching and developing products that will advance the health of ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

1965 - On 5th February, the Company entered into an agreement with C.H. Boehringer Sohn, Ingelheim am Rhein (also known as Hoehringer Ingelheim GmbH) who agreed to give the Company free of royalty ...

This change replaces the previous ticker symbol "TCJH." The transition to the new ticker symbol does not require any action from the company's shareholders. Top KingWin's shares will continue to ...

Try refreshing your browser, or tap here to see other videos from our team. PlantX Life Inc. Announces Name Change and New Ticker Symbol as Part of Rebranding Effort to Focus on Wellness-Focused ...

The Board of Directors approved the Name Change and the Company will trade on the CSE under the new symbol "JIVA ... under its new name and the new ticker symbol "JIVA" on or about November ...